Critical analysis of reference studies on the toxicokinetics of aluminum-based adjuvants

Under 6 year-olds – 1,146,530 (yes, that’s well over a million!) and breaking down this figure
Less than 1 year olds – 274,804
2-3 year olds – 370,778
4-5 year olds – 500,948
6-12 Year olds – 4,130,340
13-17 Year olds – 3,617,593
If parents refuse to get their child (vaccinated ) or medicated on a potentially life-destroying psychiatric drug then they could find themselves charged with “gross medical neglect” by the CPS (Child Protective Service) READ MORE….
VLA Comment: There are kids as young as three being diagnosed as ADHD. Wake up folks, The cause is the 49 vaccine doses given to all American children by mandate in order to go to school. The first one Hep B at birth with 400 mcgs of Aluminum and the Vitamin K shot with 100 mcgs of Aluminum…right after the cord gets cut!!!

The only reason that “children who get the chickenpox vaccine APPEAR to have a much lower risk of shingles” is that the live vaccine has provided these children with a recent boost to their immunity. However, the vaccine-strain of varicella zoster virus (VZV)–also known as the Oka strain–is genetically different from the wild-type U.S. strain. When a vaccinated child is exposed to an adult with shingles or a child with wild-type varicella, if the strains are sufficiently heterologous, the vaccinated child will break out in chickenpox. It is also possible for the weakened vaccine-strain to revert to a more virulent strain that manifests wild-type pathology. This means when children are exposed to the wild-type strain, even though they may not have a breakthrough infection with chickenpox, they now harbor two heterologous (genetically different) strains of VZV–both of which are at a later time subject to reactivation as shingles. Thus, as they age, they will be even more likely to reactivate with shingles (unless periodically administered booster vaccine doses for life in order to maintain the immunity)–especially if they do not receive exogenous (outside) boosts to their cell-mediated immunity which, in the pre-vaccine era, came from expostures to other children infected with wild-type varicella which provided the adult with a subclinical boost that helped to suppress or postpone reactivattion of shingles.
I would also like to clear up the point that shingles has always been increasing–even prior to the licensing of the varicella vaccine. This statement is true; however, the increases were on the order of 2 to 4% per year (which were likely due to an aging population, or greater access to healthcare). Once a community had widespread distribution of varicella vaccine, increases in herpes zoster were on the order of 20% per year. For example, this source [Yih WK, Brooks DR, Lett SM, et al. The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003. BMC Public Health 2005; 5:68.
32. Schmid DS, Jumaan AO. Impact of varicella vaccine on varicella-zoster virus dynamics. Clin Microbiol Rev 2010; 23(1):202–217] found a 90% increase in shingles over 5 years (1999-2003).

On May 17, 2017, we learned that Chris Cornell of Soundgarden had reportedly committed suicide by hanging. His family reports knowing a different Chris than one who would make this fatal decision, and suspect his anti-anxiety prescription in the altered state he was witnessed to be in the night he died. Perhaps an “addict turned psychiatric patient”, like so many, Chris Cornell seemed to have left the frying pan of substance abuse for the fire of psychiatric medication risks.
READ More…

Adverse reactions
In developed countries, the schedules of mandatory and recommended vaccination for children contain more and more components with a specific emphasis on the co-administration of multiple antigens in combined form. This direction on the one hand provides many benefits and on the other carries an increased risk of side effects, the immunopathogenesis of which is not fully explained in many cases [1]. READ STUDY: prog-health-sci-2012-vol-2-no1-neurologic-adverse-events-vaccination.
A postvaccinal complication (PC) is associated with an excessive or pathological reaction with the characteristics of postvaccinal disease, which in extreme cases can lead to permanent damage, threat to life or even death [3]. Complications affecting the nervous system raise the most controversy; the more so, as the children subjected to vaccination are healthy.

Young women whose lives were destroyed by the HPV vaccine.
Visualising aluminium in the human brain
Matthew Mold & Christopher Exley, The Birchall Centre, Lennard Jones Laboratories, Keele University, UK.
The evidence for the ASIA syndrome -The registry and epidemiological studies
A. Watad Sheba Medical Center, Department of Medicine ‘B’- Sheba Medical Center- Tel-Hashomer- Israel., Tel Hashomer, Israel
Suspected adverse effects after human papillomavirus vaccination: a temporal relationship between vaccine administration and the appearance of symptoms in Japan
S. Ikeda – Intractable Disease Care Center, Shinshu University Hospital, Matsumoto, Japan
HPV vaccination syndrome. A new tragic fibromyalgia model?
M. Martinez-Lavin1
1Jefe. Departamento de Reumatología, Chief, Rheumatology Department, Instituto Nacional de Cardiología. México
HPV and Lupus: the virus, the vaccine and the disease
Y. Segal1, M. Calabrò2, D. Kanduc3, Y. Shoenfeld1,4
1Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, affiliated with the Sackler Faculty of Medicine, Tel-Aviv University, Israel
2Department of Emergency and Organ Transplantation, University of Bari, Italy
3Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari,
Italy
4Incumbent of the Laura Schwarz-Kipp chair for research of autoimmune diseases, Sackler
Faculty of Medicine, Tel Aviv University, Israel
Cardiac arrest following HPV vaccination
S. Dahan1,2, Y. Segal1,2, M. Eldar4, D. Kanduc5, Y. Shoenfeld1,3
1Zabludowicz Center for Autoimmune Diseases Sheba Medical Center, Tel-Hashomer, Israel
2Sackler Faculty of Medicine, Tel Aviv University, Israel
3Incumbent of the Laura Schwarz-Kipp chair for research of autoimmune diseases, Sackler
Faculty of Medicine, Tel Aviv University, Israel
4The Neufeld Cardiac Research Institute, The Heart Institute, Chaim Sheba Medical Center,
Ramat Gan, Israel
5Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, Bari,
Italy
Immunogenicity and Safety of Viral and Bacterial Vaccinations in Lupus Subjects
N. Bragazzi1
1University of Genoa, School of Public Health- Department of Health Sciences DISSAL, Genoa, Italy
Elucidating the relationship between the concentration of aluminium salts used in vaccines and the subsequent events occurring at the injection site.
Emma Shardlow, Matthew Mold, Christopher Exley, The Birchall Centre, Lennard-Jones Laboratories, Keele University, UK
Experimental evaluation of the toxicokinetics of aluminum-based adjuvants: what’s wrong in the reference studies?
Jean-Daniel Masson1*, Guillemette Crépeaux1,2*, François-Jérôme Authier1, Christopher Exley3, Romain K Gherardi11 INSERM U955 E10, « Biologie du système neuromusculaire », Faculté de Médecine, Université Paris , France2 Génétique médicale comparée des affections neuromusculaires, Ecole Nationale Vétérinaire d’Alfort, Maisons-Alfort, France3 The Birchall Centre, Lennard-Jones Laboratories, Keele University, UK
Neurodevelopmental Toxicity of Vaccines in a Rodent Model
Housam Eidi1, Janice Yoo1, Michael Kuo1 and Christopher A. Shaw1 1 Dept. of Ophthalmology and Visual Sciences, University of British Columbia, Canada
Cerebral 18F-FDG PET for diagnosing aluminum hydroxide-induced macrophagic myofasciitis
Blanc-Durand Paul, Van Der Gucht Axel, Guedj Eric, Aoun-Sebaiti Mehdi, Gherardi Romain K., Itti Emmanuel, Authier F. Jérôme Reference Center for Neuromuscular Disorders, H. Mondor Hospital, Assistance Publique-Hôpitaux de Paris ; INSERM U955-Team 10, Paris Est-Creteil University, France. (10) INSERM U955-GRC Amyloid Research Institute, Créteil, France.
Clinicopathologic studies in lambs repetitively inoculated with aluminum adjuvant containing products
Asín1, J. Molín1, M. Pérez1, P. Pinczowski1, M. Gimeno1, M Pascual-Alonso1, N. Navascués, A1. Muniesa1, I. de Blas1, G. María1, D. Lacasta1, A. Fernández1, L. de Pablo2, M. Mold3, C. Exley3, D. de Andrés2, R. Reina2, L. Luján1 1. University of Zaragoza, Spain 2. Institute of Agrobiotechnology, CSIC-Public University of Navarra, Spain 3. The Birchall Centre, Keele University, Keele, Staffordshire, UK

VLA COMMENT: FLUAD is a new experimental vaccine for senior. It contains the same adjuvant at that which is used in the Anthrax vaccine causing “Gulf War syndrome”. Watch Direct order

“…most ‘flu’ appears to have nothing to do with influenza. Every year, hundreds of thousands of respiratory specimens are tested across the US. Of those tested, on average 16% are found to be influenza positive.” – From the British Medical Journal editor, Peter Doshi, MD
“71 people would need to be treated with the flu vaccine to prevent one case. In other words, the flu vaccine did nothing for 70 out of 71 who received it. That means this study found the flu vaccine failed 99% (70/71).” — Dr David Brownstein
“Under ideal conditions (when the vaccine actually matches the main viruses circulating that season) you need to vaccinate 33 healthy adults to avoid one set of influenza symptoms. 33 is what is called the NNV (Number Needed to Vaccinate).” – Dr Tom Jefferson of the Cochrane Collaboration (Cochrane Database Syst. Rev. 2018. Feb. 1,2:CD001269)
“…influenza virus often mutates to adapt to being grown in chicken eggs, which can influence antigenicity and hence vaccine effectiveness.” — Ian A. Wilson, MD, et al from: “A Structural Explanation for the Low Effectiveness of the Seasonal Influenza H3N2 Vaccine. (http://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1006682)
“Between 33 and 100 people are needed to vaccinate to prevent one case of flu symptoms.” – Alan Cassals, author of Selling Sickness: Medical Screening and the Misguided Hunt for Disease
“Normally, the flu vaccine is between 50 to 60 percent effective.” — Dr. Tom Frieden, Director of the Centers for Disease Control and Prevention (CDC)
VLA COMMENT: BYW…The shingles vaccines is 90% ineffective for seniors.